# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added ...
Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Mon...
Johnson & Johnson reported successful Phase 3 trial results for seltorexant, an investigational treatment for major depress...
https://www.jnj.com/media-center/press-releases/johnson-johnson-pivotal-study-of-seltorexant-shows-statistically-significant-an...
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest w...
U.S. Supreme Court urged by Biden administration to reconsider terrorism funding ruling involving major pharmaceutical and medi...
Cancer victims have filed a lawsuit against Johnson & Johnson, accusing the company of fraudulently using a shell company...